 |
|
|
| |
CDC Viral Load Suppression Reporting
|
| |
| |
Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data United States and 6 Dependent Areas, 2016
According to the Table 5a of the CDC's Monitoring report (https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-23-4.pdf) , 59.8% of people living with diagnosed HIV infection had the last VL test < 200 copies in 2015.
Viral suppression
Viral suppression was measured for persons with HIV infection diagnosed by year-end 2014 and alive at year-end 2015 in the 40 jurisdictions that reported complete CD4 and viral load test results to CDC. Viral suppression was defined as a viral load result of <200 copies/mL at the most recent viral load test during 2015.
During 2015, 73.4% of 794,145 persons had at least 1 CD4 or viral load test (i.e., received any care in 2015), and 70.3% had at least 1 viral load test. At the most recent viral load test during 2015, viral load was suppressed in 81.5% of persons who received care (at least 1 CD4 or viral load test) in 2015 and in 85.2% of persons with a viral load test during 2015. The persons with suppressed viral load represented 59.8% of the total number of persons with an HIV diagnosis by year-end 2014 and alive at year-end 2015 in the 40 jurisdictions (Table 5a).
The following percentages are for persons whose most recent viral load test result in 2015 indicated viral suppression (denominator: persons who were alive at year-end 2015).
•Age group: The percentage increased as age increased (51.2% [persons aged 13–24 years]; 62.8% [persons aged ≥55 years]).
•Race/ethnicity: The highest percentage was for persons of multiple races (68.1%), followed by whites (66.6%), Asians (65.0%), Native Hawaiians/other Pacific Islanders (60.8%), Hispanics/Latinos (60.0%), American Indians/Alaska Natives (58.8%), and blacks/African Americans (54.0%).
•Transmission category: The highest percentage was for males with infection attributed to male-to-male sexual contact (63.0%), followed by males with infection attributed to male-to-male sexual contact and injection drug use (60.1%).
https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-23-4.pdf
|
| |
|
|
|
|
|
